Följ
Venu Chalasani
Venu Chalasani
University of Sydney
Verifierad e-postadress på tpg.com.au
Titel
Citeras av
Citeras av
År
Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer
V Chalasani, JL Chin, JI Izawa
Canadian Urological Association Journal 3 (6 Suppl 4), S193, 2009
2672009
The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the …
L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ...
European urology 80 (6), 682-689, 2021
2282021
Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with …
IA Thangasamy, V Chalasani, A Bachmann, HH Woo
European urology 62 (2), 315-323, 2012
2162012
Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen …
L Emmett, C Yin, M Crumbaker, G Hruby, A Kneebone, R Epstein, ...
Journal of Nuclear Medicine 60 (7), 950-954, 2019
1732019
Use of Clavien-Dindo classification in reporting and grading complications after urological surgical procedures: analysis of 2010 to 2012
PD Yoon, V Chalasani, HH Woo
The Journal of urology 190 (4), 1271-1274, 2013
1402013
Use of Clavien-Dindo classification in reporting and grading complications after urological surgical procedures: analysis of 2010 to 2012
PD Yoon, V Chalasani, HH Woo
The Journal of urology 190 (4), 1271-1274, 2013
1402013
Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and …
RJS Calopedos, V Chalasani, R Asher, L Emmett, HH Woo
Prostate Cancer and Prostatic Diseases 20 (3), 352-360, 2017
872017
Conversion rates of abstracts presented at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting into full‐text journal articles
PD Yoon, V Chalasani, HH Woo
BJU international 110 (4), 485-489, 2012
682012
Intravesical chemotherapy plus bacille C almette‐G uérin in non‐muscle invasive bladder cancer: a systematic review with meta‐analysis
BB Houghton, V Chalasani, D Hayne, P Grimison, CSB Brown, MI Patel, ...
BJU international 111 (6), 977-983, 2013
642013
Whole‐gland salvage high‐intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy
H Uddin Ahmed, P Cathcart, V Chalasani, A Williams, N McCartan, ...
Cancer 118 (12), 3071-3078, 2012
622012
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen …
A Amin, A Blazevski, J Thompson, MJ Scheltema, MS Hofman, D Murphy, ...
BJU international 125 (4), 515-524, 2020
602020
Systematic review and meta-analysis on management of acute urinary retention
PD Yoon, V Chalasani, HH Woo
Prostate Cancer and Prostatic Diseases 18 (4), 297-302, 2015
572015
An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?
E Feletto, A Bang, D Cole-Clark, V Chalasani, K Rasiah, DP Smith
World journal of urology 33, 1677-1687, 2015
532015
An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?
E Feletto, A Bang, D Cole-Clark, V Chalasani, K Rasiah, DP Smith
World journal of urology 33, 1677-1687, 2015
532015
Salvage HIFU for recurrent prostate cancer after radiotherapy
V Chalasani, CH Martinez, D Lim, J Chin
Prostate cancer and prostatic diseases 12 (2), 124-129, 2009
512009
Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression
TD Palmer, CH Martínez, C Vasquez, KE Hebron, C Jones-Paris, ...
Cancer research 74 (1), 173-187, 2014
502014
Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180‐W Greenlight lithium triborate laser
GL Knapp, V Chalasani, HH Woo
BJU international 119, 33-38, 2017
412017
Development and validation of a virtual reality transrectal ultrasound guided prostatic biopsy simulator
V Chalasani, DW Cool, S Sherebrin, A Fenster, J Chin, JI Izawa
Canadian Urological Association Journal 5 (1), 19, 2011
352011
Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience
V Chalasani, W Kassouf, JL Chin, Y Fradet, AG Aprikian, AS Fairey, ...
Canadian Urological Association Journal 5 (2), 83, 2011
292011
Cumulative summation graphs are a useful tool for monitoring positive surgical margin rates in robot‐assisted radical prostatectomy
AK Williams, V Chalasani, CH Martínez, E Osbourne, L Stitt, JI Izawa, ...
BJU international 107 (10), 1648-1652, 2011
282011
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20